Last week’s hot topic on BPH was Benign Prostatic Hyperplasia Review Looks at Range of Treatment Options Now Available written by Magdalena Kegel.
This article was about choices for treating the symptoms of benign prostatic hyperplasia (BPH) and how they have never been so great and, with the needs of BPH patients as varied as the treatments available, there is no “one-size-fits-all” solution to BPH management, according to a review, “Recent advances in treatment for Benign Prostatic Hyperplasia,“ published in the journal F1000Research.
The authors argued that the future of BPH treatments likely lies in the combination of drugs targeting the complex interactions between bladder receptors, neural pathways, and structural changes. On the technological front, many novel and current techniques have yet to prove their superiority over traditional techniques. But a personalized approach to treatment is undoubtedly the way to go. It is a step away from recommendations of first and second-lines of treatment toward personal choices made by the treating physician, in discussion with the patient, to determine an optimal and individual treatment plan.